DBS trial for difficult-to-treat Tourette syndrome shows promise
Human trial of closed-loop DBS in four participants with difficult-to-treat Tourette syndrome finds treatment to be safe, beneficial.
Posts tagged as
Norman Fixel Institute
Research Snapshot: Dr. Christopher Butson and Chantel Charlebois
Study indicates that focusing neurostimulation on specific brain networks could reduce seizures in mesial temporal lobe epilepsy.
